BMI View: We expect Bahrain's pharmaceutical market will grow moderately in the coming years, with
spending set to be bolstered by the eventual implantation of a national health insurance scheme. Over the
longer term, the county's growing obesity levels will contrib ..."
BMI View: Bahrain's pharmaceutical market will experience slight growth in 2016 as a result of medicine
price cuts implemented in late 2015. The country's rising prevalence of lifestyle-related diseases and the
uptake of compulsory health insurance will provide strong ..."
BMI View: Bahrain's government will continue in its attempts to attract investments and expand domestic
pharmaceutical manufacturing. Although there will be an expansion of local drug production, foreign
drugmakers will continue to view Bahrain as an unattractive opti ..."
BMI View: Bahrain's healthcare sector will become increasingly privatised following the exclusion of
expatriates from the public health system and the eventual implementation of compulsory health insurance.
Public spending will also grow, albeit at a slower pace, with ..."
BMI View: Bahrain's government will continue in its attempts at containing the rapidly expanding cost of
healthcare. Private sector engagement and increasing generic substitution will continue to be employed,
although government spending on the sector will continue to ..."
BMI View: We uphold our view that Bahrain's pharmaceutical and healthcare sector will maintain strong
and consistent growth over our forecast period. We believe that the country's ageing population will help
drive medicine demand along with an increasing chronic disea ..."
BMI View: Bahrain's National Health Regulatory Authority has begun implementing its multi-phased plan
to significantly reduce medicine prices in the country. The price cuts are the result of a Gulf Cooperation
Council decision to unify the cost of medication in the re ..."
BMI View: This quarter has seen the beginning of a multi-phased plan by the National Health Regulatory
Authority to significantly reduce medicine prices in the country, signalling a potential advancement towards
the implementation of a unified Gulf Cooperation Council ..."
BMI View: We remain cautiously positive about Bahrain's longer-term pharmaceutical market outlook. On
the one hand, the population's relative wealth and the absence of a strong domestic pharmaceutical market
will continue to support imports of novel medicines. On the ..."
BMI View: Bahrain's wealth will continue to attract research-based pharmaceutical manufacturers. We
therefore expect the value of the country's patented drug market to continue on its steady upward trajectory.
However, annual growth rates of its generic counterpart will be cons ..."